PERİODONTAL HASTALIKLI BİREYLERDE PRO İNFLAMATUAR SİTOKİN GEN POLİMORFİZMLERİNİN DEĞERLENDİRİLMESİ

Yıl 2022, Cilt: 32 Sayı: 3, 196 - 200, 14.07.2022

Özlem Fentoğlu Eda Evgen Tülüceoğlu Esra Sinem Kemer Doğan Burak Doğan

https://doi.org/10.54614/CRDS.2022.6203

Öz

Amaç: Periodontal hastalıklar, pro-inflamatuar sitokin yanıtındaki artışla gözlenen epigenetik karakterli kronik inflamatuar patolojilerdir. Bu çalişmada, periodontal hastalıklı bireylerde pro-inflamatuar sitokin (interlökin (IL)-1β, tümör nekrozis faktör-alfa (TNF-α) ve IL-6) gen polimorfizmlerini değerlendirmeyi amaçladık. Yöntemler: Bu çalışmaya periodontitisli (n = 25), gingivitisli (n = 22) ve periodontal olarak sağlıklı kontroller (n = 18) olmak üzere toplam 65 birey dahil edildi. Periodontal parametreler (plak indeksi, gingival indeks, sondalama cebi derinliği, sondalamada kanama yüzdesi ve klinik tutunma seviyesi) kaydedildi ve açlık venöz kan örnekleri alındı. TNF-α-308, -238, IL-1β -511, +3953 ve IL-6 -174 ve -572 polimorfizmlerinin genotipleri ve alel frekansları polimeraz zincir reaksiyonu-kısıtlı parça uzunluğu polimorfizmi tekniği kullanılarak yapıldı. Bulgular: IL-1β +3953, IL-6 -174 ve TNF-α-238 heterozigot genotipleri, klinik periodontal parametreler ve de mografik özellikler periodontitisli bireylerde artış gösterdi. IL-1β +3953 (risk alel 2 (A alel) (GA genotipi) periodontitis riskini arttırırken, IL-6 -174 (risk aleli 2 (G/T alleli) (CG/CT genotipleri) gingivitis ile ilişkiliydi. Sonuç: Bulgularımız, pro-inflamatuar sitokin gen polimorfizmlerinin gingivitis ve periodontitis patogenezinde etkili olabileceğine dair önemli kanıtlar sunmaktadır. Periodontal hastalıklarla ilişkili sitokin yanıtının kontrolü pek çok enfeksiyöz-inflamatuar hastalıkla ilişkili mortalite ve morbidite oranlarının azaltarak halk sağlığının arttırılmasına yönelik bir adım oluşturabilir.
Anahtar Kelimeler: İnterlökin 6, interlökin-1 beta, diş eti iltihabı, periodontit, polimorfizm, tümör nekrozis faktör alfa
ABSTRACT
Objective: Periodontal diseases are chronic inflammatory pathologies including in pro-inflammatory cytokine-mediated pathogenesis and epigenetic characteristics. We aimed to evaluate pro-inflammatory cytokine [interleukin (IL)-1β, tumour necrosis factor-alpha (TNF-α), and IL-6] gene polymorphisms in patients with periodontal disease. Methods: Patients with periodontitis (n = 25), gingivitis (n = 22), and periodontally healthy controls (n = 18) were enrolled in this study. The periodontal parameters (plaque index, gingival index, probing pocket depth, percent age of bleding on probing, and clinical attachment level) were recorded, and fasting venous blood samples were obtained. The genotypes and allele frequencies of TNFα -308, -238, IL-1β -511, +3953, IL-6 -174, -572 polymorphisms were performed using polymerase chain reaction–restriction fragment length polymorphism technique. Results: Patients with periodontitis had the highest IL-1β +3953, IL-6 -174 ve TNF-α -238 heterozygot genotypes, clinical periodontal parameters and demographic characteristics. IL-1β +3953 [the risk allele 2 (A allele) (GA genotype)] led to an increased risk of periodontitis, IL-6 -174 [the risk allele 2 (G/T allele) (CG/CT genotypes)] was associated with gingivitis. Conclusion: Our findings provide important evidence that pro-inflammatory cytokine gene polymorphisms may be involved in the pathogenesis of gingivitis and periodontitis. Control of the cytokine response associated with periodontal diseases may constitute a step towards improving public health by reducing mortality and morbidity rates associated with many infectious-inflammatory diseases.
Keywords: Interleukine-6, interleukin-1 beta, gingivitis, periodontitis, polymorphism, tumor necrosis factor alpha

Anahtar Kelimeler

İnterlökin 6, interlökin-1 beta, diş eti iltihabı, periodontit, polimorfizm, tümör nekrozis faktör alfa

Kaynakça

• 1. Eke PI, Dye BA, Wei L, Thornton-Evans GO, Genco RJ. Prevalence of periodontitis in adults in the United States: 2009 and 2010. J Dent Res. 2012;91(10):914-920. [Crossref]
• 2. Armingohar Z, Jorgensen JJ, Kristoffersen AK, Schenck K, Dembic Z. Polymorphisms in the interleukin-1 gene locus and chronic periodontitis in patients with atherosclerotic and aortic aneurysmal vascular diseases. Scand J Immunol. 2014;79(5):338-345. [Crossref]
• 3. Loos BG, Van Dyke TE. The role of inflammation and genetics in peri odontal disease. Periodontol 2000. 2020;83(1):26-39. [Crossref]
• 4. Beck JD, Papapanou PN, Philips KH, Offenbacher S. Periodontal medicine: 100 years of progress. J Dent Res. 2019;98(10):1053-1062. [Crossref]
• 5. Kasımoğlu Y, Koruyucu M, Seymen F. Diş hekimliğinde gen tedavisi (Derleme). Curr Res Dent Sci. 2019;29(4):691-700. [Crossref]
• 6. Kinane DF, Shiba H, Hart TC. The genetic basis of periodontitis. Periodontol 2000. 2005;39(1):91-117. [Crossref]
• 7. Hart TC, Marazita ML, Wright JT. The impact of molecular genetics on oral health paradigms. Crit Rev Oral Biol Med. 2000;11(1):26-56. [Crossref]
• 8. Pritchard JK. Are rare variants responsible for susceptibility to com plex diseases?. Am J Hum Genet. 2001;69(1):124-137. [Crossref]
• 9. Alayan J, Gemmell E, Ford P, et al. The role of cytokines in a Porphy romonas gingivalis-induced murine abscess model. Oral Microbiol Immunol. 2007;22(5):304-312. [Crossref]
• 10. Darveau RP. Periodontitis: a polymicrobial disruption of host homeo stasis. Nat Rev Microbiol. 2010;8:481-490. [Crossref] 11. Jahandideh B, Derakhshani M, Abbaszadeh H, et al. The pro-Inflam matory cytokines effects on mobilization, self-renewal and differen tiation of hematopoietic stem cells. Hum Immunol. 2020;81(5):206- 217. [Crossref] 12. Williams JW, Huang LH, Randolph GJ. Cytokine circuits in cardiovas cular disease. Immunity. 2019;50(4):941-954. [Crossref]
• 13. Kumar S. Evidence-based update on diagnosis and management of gingivitis and periodontitis. Dent Clin North Am. 2019;63(1):69-81. [Crossref]
• 14. Fentoglu O, Oz G, Tasdelen P, Uskun E, Aykac Y, Bozkurt FY. Peri odontal status in subjects with hyperlipidemia. J Periodontol. 2009;80(2):267-273. [Crossref]
• 15. Silness J, Löe H. Periodontal disease in pregnancy II. Correlation be tween oral hygiene and periodontal condition. Acta Odontologica Scandinavica. 1964;22(1):121-135. [Crossref]
• 16. Loe H, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand. 1963;21(6):533-551. [Crossref]
• 17. Chapple ILC, Mealey BL, Van Dyke TE, et al. Periodontal health and gingival diseases and conditions on an intact and a reduced periodontium: Consensus report of workgroup 1 of the 2017 World Workshop on the classification of periodontal and peri-implant diseases and conditions. J Clin Periodontol. 2018;45(Suppl 20):S68-S77. [Crossref]
• 18. Tonetti MS, Greenwell H, Kornman KS. Staging and grading of periodontitis: Framework and proposal of a new classification and case definition. J Clin Periodontol. 2018;45(Suppl 20):S149-S161. [Crossref]
• 19. Heidari Z, Moudi B, Sagheb HM, Moudi M. Association of TNF-α gene polymorphisms with production of protein and susceptibility to chronic hepatitis B infection in the south east Iranian population. Hepatitis Monthly. 2016;16(11):e41984. [Crossref]
• 20. Singh PK, Chandra G, Bogra J, et al. Association of interleukin-6 genetic polymorphisms with risk of OSCC in Indian population. Meta Gene. 2015;4:142-151. [Crossref]
• 21. Zhang PA, Li Y, Xu P, Wu JM. Polymorphisms of interleukin-1B and in terleukin-1 receptor antagonist genes in patients with chronic hepa titis B. World J Gastroenterol. 2004;10(12):1826-1829. [Crossref]
• 22. Fentoğlu Ö, Köroğlu BK, Hiçyılmaz H, et al. Pro-inflammatory cyto kine levels in association between periodontal disease and hyperlipidaemia. J Clin Periodontol. 2011;38(1):8-16. [Crossref]
• 23. Boyapati R, Vudathaneni V, Nadella SB, Ramachandran R, Dhulipalla R, Adurty C. Mapping the link between cardiac biomarkers and chronic periodontitis: a clinico-biochemical study. J Indian Soc Periodontol. 2020;24(4):309-315.
• 24. Sanz M, Marco Del Castillo A, Jepsen S, et al. Periodontitis and cardiovascular diseases: Consensus report. J Clin Periodontol. 2020;47(3):268-288. [Crossref]
• 25. Fentoglu O, Bozkurt FY. The bi-directional relationship between periodontal disease and hyperlipidemia. Eur J Dent. 2008;2(2):142-146. [Crossref]
• 26. Citterio F, Romano F, Ferrarotti F, Gualini G, Aimetti M. Quality of methods and reporting in association studies of chronic periodontitis and IL1A -889 and IL1B +3953/4 SNPs: A systematic review. J Periodontal Res. 2019;54(5):457-467. [Crossref]
• 27. Sharma N, Joseph R, Arun R, Chandni R, Srinivas KL, Banerjee M. Cytokine gene polymorphism (interleukin-1β+ 3954, Interleukin-6 [− 597/− 174] and tumor necrosis factor-α− 308) in chronic periodontitis with and without type 2 diabetes mellitus. Indian J Dent Res. 2014;25(3):375-380. [Crossref]
• 28. Majumder P, Thou K, Bhattacharya M, Nair V, Ghosh S, Dey SK. Association of tumor necrosis factor-alpha (TNF-alpha) gene promoter polymorphisms with aggressive and chronic periodontitis in the eastern Indian population. Biosci Rep. 2018;38(4):BSR20171212. [Crossref]
• 29. Craandijk J, van Krugten MV, Verweij CL, van der Velden U, Loos BG. Tumor necrosis factor-alpha gene polymorphisms in relation to periodontitis. J Clin Periodontol. 2002;29(1):28-34. [Crossref]
• 30. Fan W, Liu D, Xiao L, Xie C, Sun S, Zhang J. Coronary heart disease and chronic periodontitis: is polymorphism of interleukin-6 gene the common risk factor in a Chinese population? Oral Dis. 2011;17(3):270- 276. [Crossref]
• 31. Tanaka T, Narazaki M, Masuda K, Kishimoto T. Regulation of IL-6 in immunity and diseases. Adv Exp Med Biol. 2016;941:79-88. [Crossref]
• 32. Zhao B, Li R. The association between periodontitis and interleu kin-6 genetic polymorphism-174 G/C: A meta-analysis. Arch Oral Biol. 2018;96:13-20. [Crossref]
• 33. Struch F, Dau M, Schwahn C, Biffar R, Kocher T, Meisel P. Interleukin-1 gene polymorphism, diabetes, and periodontitis: results from the Study of Health in Pomerania (SHIP). J Periodontol. 2008;79(3):501- 507. [Crossref]